Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
The American Journal of the Medical Sciences|March 15, 2025
The TyG index correlation with invasive ventilator in critically ill patients: A retrospective analysis of the MIMIC-IV databaseJie Hu, Jie Min, Dan Zong
Mitochondrial DNA. Part B, Resources|September 13, 2021
The complete mitochondrial genome of <i>Populus rotundifolia</i> var. <i>duclouxiana</i>Xiaolin Zhang, Chengzhong He, Dan Zong
The International Journal of Neuroscience|February 14, 2026
The correlation between YTHDF1 gene polymorphism and cognitive dysfunction after radiotherapy for gliomaHuanfeng Zhu, Xiyun Shi, Dan Zong, et al.
Clinical and Translational Radiation Oncology|March 27, 2025
Predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients using a deep learning modelYichen Mao, Mingjun Ding, Dan Zong, et al.
Genes|October 27, 2022
<i>PyunBBX18</i> Is Involved in the Regulation of Anthocyanins Biosynthesis under UV-B StressQin Zhang, Dongxiao Ma, Zhixu Hu, et al.
Medicine|August 26, 2024
PD-1 inhibitor combined with SBRT, GM-CSF, and thymosin alpha-1 in metastatic breast cancer: A case report and literature reviewJiamin Yu, Qiang Wang, Lijun Wang, et al.
Cancer Medicine|May 9, 2026
Transformer-Based Deep Learning Model for Predicting Recurrence in High-Grade GliomaXin Wang, Mingjun Ding, Dan Zong, et al.
Frontiers in Oncology|September 12, 2025
First-line treatment with cadonilimab plus paclitaxel-platinum ± bevacizumab for persistent, recurrent, or metastatic cervical cancer: a retrospective real-world studyXin Wang, Chunsheng Wang, Dan Zong, et al.
Cancer Immunology, Immunotherapy : CII|October 24, 2025
Bispecific antibodies (PD-1/CTLA-4) vs. PD-1 inhibitors with platinum-based chemotherapy±bevacizumab as first-line therapy for persistent, recurrent, or metastatic cervical cancer: a retrospective matched cohort studyXin Wang, Yaqin Wu, Jian Huang, et al.
Discover Oncology|November 19, 2025
Efficacy and safety of PD-1 inhibitors combined with anti-angiogenic agents in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysisJingjing Gao, Dan Zong, Yiyue He, et al.
Pageof 11